Dipeptidyl peptidase expression during experimental colitis in mice

Recent insights into the role of dipeptidyl aminopeptidase IV (DPIV) and aminopeptidase N (APN) families in immune functions

(2009) Siegfried Ansorge et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Growth factor based therapies and intestinal disease: Is glucagon-like peptide-2 the new way forward?

(2009) Roger Yazbeck et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Dipeptidyl peptidase 8 and 9 - guilty by association?

(2009) Melissa et al.   Frontiers in Bioscience-Landmark

The In Vivo Expression of Dipeptidyl Peptidases 8 and 9

(2009) Denise M.T. Yu et al.   JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY

GLP-2 Administration Results in Increased Proliferation but Paradoxically an Adverse Outcome in a Juvenile Piglet Model of Short Bowel Syndrome

(2009) Prue M Pereira-Fantini et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease?

(2009) Roger Yazbeck et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

CD26/dipeptidyl peptidase 4-deficiency alters thymic emigration patterns and leukcocyte subsets in F344-rats age-dependently

(2008) C. Klemann et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Dipeptidyl Peptidase IV Inhibition With MK0431 Improves Islet Graft Survival in Diabetic NOD Mice Partially via T-Cell Modulation

(2008) S.-J. Kim et al.   DIABETES

Stromal cell-derived factors 1α and 1β, inflammatory protein-10 and interferon-inducible T cell chemo-attractant are novel substrates of dipeptidyl peptidase 8

(2008) Katerina Ajami et al.   FEBS LETTERS

Inhibiting dipeptidyl peptidase activity partially ameliorates colitis in mice

(2008) Roger Yazbeck   Frontiers in Bioscience-Landmark